1. World Health Organization
20 July, 2018
Countries using and
planning to introduce IPV
and the global status of
bOPV registration

2. World Health Organization
20 July 2018
Countries using and planning to introduce IPV November 2016 status report
This slide deck provides a summary per country on the status of planning for the introduction of Inactivated Poliomyelitis Vaccine (IPV).
It also includes a summary of the global status of national registration of bivalent Oral Polio Vaccine (bOPV), in preparation for the switch from trivalent OPV (tOPV) to bOPV.
Information here is updated monthly based on information shared by WHO and UNICEF Regional Offices. Please contact with any questions or updates on this data.
Definitions
Formal decision to introduce: The country has documentation of its decision to introduce IPV which has been verified by the relevant WHO Regional Office, or for Gavi eligible countries, a complete application for IPV has been submitted to the Gavi Secretariat.
Intent to introduce: The country has informally indicated that it plans to introduce IPV, e.g. planning an application to Gavi, or by requesting technical assistance to develop an IPV introduction plan.
Tracking these decisions and informal intents provide an indication of the global trend towards meeting the targets of the Polio Eradication and Endgame Strategic Plan.

3. Countries using IPV vaccine to date and formal decision to introduce
World Health Organization
20 July, 2018
Introduced to date
Afghanistan Albania Algeria Andorra Antigua and Barbuda Argentina Armenia Australia Austria Azerbaijan Bahamas (the) Bahrain Bangladesh Barbados Belarus Belgium Belize Benin Bhutan Bolivia (Plurinational State of) Bosnia and Herzegovina Botswana Brazil Brunei Darussalam Bulgaria Burundi Cambodia Cameroon Canada Central African Republic (the) Chad Chile China Colombia Comoros (the) Congo (the) Cook Islands Costa Rica Cote d'Ivoire Croatia Cuba Cyprus Czech Republic (the) Denmark Djibouti Dominica Dominican Republic (the) DPR Korea DR Congo Ecuador El Salvador Equatorial Guinea Estonia Ethiopia Fiji Finland France Gabon Gambia (the) Georgia Germany Greece Grenada Guatemala Guinea Guinea-Bissau Guyana Haiti Honduras Hungary Iceland India Indonesia Iran (Islamic Republic of) Iraq Ireland Israel Italy Jamaica Japan Jordan Kazakhstan Kenya Kiribati Kuwait Lao People's Democratic Republic (the) Latvia Lebanon Lesotho Libya Lithuania Luxembourg Madagascar Malaysia Maldives Mali Malta Marshall Islands (the) Mauritania Mauritius Mexico Micronesia (Federated States of) Monaco Montenegro Morocco Mozambique Myanmar Namibia Nauru Nepal Netherlands (the) New Zealand Nicaragua Niger (the) Nigeria Niue Norway Oman Pakistan Palau Panama Papua New Guinea Paraguay Peru Philippines (the) Poland Portugal Qatar Rep of Korea Romania Russian Federation (the) Saint Kitts and Nevis Saint Lucia Saint Vincent and the Grenadines Samoa San Marino Sao Tome and Principe Saudi Arabia Senegal Serbia Seychelles Singapore Slovakia Slovenia Solomon Islands Somalia South Africa South Sudan Spain Sri Lanka Sudan (the) Suriname Swaziland Sweden Switzerland Syrian Arab Republic (the) Thailand The former Yugoslav Republic of Macedonia Timor-Leste Tonga Trinidad and Tobago Tunisia Turkey Tuvalu Uganda Ukraine United Arab Emirates (the) United Kingdom of Great Britain and Northern Ireland (the) United States of America (the) Uruguay Vanuatu Venezuela (Bolivarian Republic of) Yemen
Introduction delayed to 2017
Angola Burkina Faso Cabo Verde Egypt Eritrea Ghana Kyrgyzstan Liberia Malawi Mongolia Republic of Moldova (the) Rwanda Sierra Leone Tajikistan Togo Turkmenistan United Republic of Tanzania (the) Uzbekistan Viet Nam Zambia Zimbabwe
Since January 2013, the following countries have introduced IPV: Kazakhstan, Peru & Singapore (July 2013); Micronesia (August 2013); Libya (April 2014); Albania & Panama (May 2014); Nepal & Tunisia (September 2014); Philippines (October 2014); China (December 2014); Comoros, Senegal & Serbia (January 2015); Colombia & Nigeria (February 2015); Bangladesh & Maldives (March 2015); DR Congo, DPR Korea & The Gambia (April 2015); Madagascar (May 2015); Cote d'Ivoire, Grenada, Kiribati, Morocco, St Vincent and the Grenadines & Sudan (June 2015); Bhutan, Cameroon, Niger, Pakistan, Philippines & Sri Lanka (July 2015); Benin, Chad, Papua New Guinea, The Former Yug. Rep. of Macedonia (August 2015); Afghanistan, CAR, Dominica, Guyana, Iran, Jamaica, Seychelles & Solomon Islands (September 2015); Bahamas, Lao People's Dem Rep, Nauru, Samoa (October 2015); Antigua and Barbuda, Botswana, Burundi, Cook Islands, Guinea, India, Mauritania, Mauritius, Mozambique, Namibia, Nicaragua, St Lucia, Suriname, Tuvalu, Vanuatu & Yemen (November 2015); Algeria, Belize, Cambodia, Dominical Rep, Ecuador, Ethiopia, Fiji, Gabon, Georgia, Honduras, Kenya, Myanmar, Paraguay, St Kitts & Nevis, S. Sudan, Thailand, Tonga & Trinidad & Tobago (December 2015); Cuba, El Salvador, Guatemala, Haiti, Iraq & Venezuela (Bolivian Rep of) (January 2016); Azerbaijan, Bolivia & Timor-Leste (February 2016); Chile & Mali (March 2016); Argentina, Congo, Djibouti, Lesotho, Sao Tome & P., Uganda (April 2016); Armenia, Guinea-Bissau, Indonesia & Swaziland (July 2016); Eq. Guinea (August 2016)
Introduced* to date (173 countries or 89%)
Introduction delayed to (21 countries or 11%)
Not available
Not applicable
Data source: WHO/IVB Database, as of 07 November 2016
Map production Immunization Vaccines and Biologicals (IVB),
World Health Organization
* Including partial introduction in India
The boundaries and names shown and the designations used on this map do not imply the expression of any opinion whatsoever on the part of the World Health Organization concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries. Dotted lines on maps represent approximate border lines for which there may not yet be full agreement. ©WHO All rights reserved.
Date of slide: 7 November 2016

4. World Health Organization
Countries using IPV vaccine to date and introductions planned according to Gavi eligibility status
World Health Organization
20 July, 2018
Introduced to date
Afghanistan Albania Algeria Andorra Antigua and Barbuda Argentina Armenia Australia Austria Azerbaijan Bahamas (the) Bahrain Bangladesh Barbados Belarus Belgium Belize Benin Bhutan Bolivia (Plurinational State of) Bosnia and Herzegovina Botswana Brazil Brunei Darussalam Bulgaria Burundi Cambodia Cameroon Canada Central African Republic (the) Chad Chile China Colombia Comoros (the) Congo (the) Cook Islands Costa Rica Cote d'Ivoire Croatia Cuba Cyprus Czech Republic (the) Denmark Djibouti Dominica Dominican Republic (the) DPR Korea DR Congo Ecuador El Salvador Equatorial Guinea Estonia Ethiopia Fiji Finland France Gabon Gambia (the) Georgia Germany Greece Grenada Guatemala Guinea Guinea-Bissau Guyana Haiti Honduras Hungary Iceland India Indonesia Iran (Islamic Republic of) Iraq Ireland Israel Italy Jamaica Japan Jordan Kazakhstan Kenya Kiribati Kuwait Lao People's Democratic Republic (the) Latvia Lebanon Lesotho Libya Lithuania Luxembourg Madagascar Malaysia Maldives Mali Malta Marshall Islands (the) Mauritania Mauritius Mexico Micronesia (Federated States of) Monaco Montenegro Morocco Mozambique Myanmar Namibia Nauru Nepal Netherlands (the) New Zealand Nicaragua Niger (the) Nigeria Niue Norway Oman Pakistan Palau Panama Papua New Guinea Paraguay Peru Philippines (the) Poland Portugal Qatar Rep of Korea Romania Russian Federation (the) Saint Kitts and Nevis Saint Lucia Saint Vincent and the Grenadines Samoa San Marino Sao Tome and Principe Saudi Arabia Senegal Serbia Seychelles Singapore Slovakia Slovenia Solomon Islands Somalia South Africa South Sudan Spain Sri Lanka Sudan (the) Suriname Swaziland Sweden Switzerland Syrian Arab Republic (the) Thailand The former Yugoslav Republic of Macedonia Timor-Leste Tonga Trinidad and Tobago Tunisia Turkey Tuvalu Uganda Ukraine United Arab Emirates (the) United Kingdom of Great Britain and Northern Ireland (the) United States of America (the) Uruguay Vanuatu Venezuela (Bolivarian Republic of) Yemen
Gavi countries with formal commitment to introduce in 2017
Angola Burkina Faso Eritrea Ghana Kyrgyzstan Liberia Malawi Mongolia Republic of Moldova (the) Rwanda Sierra Leone Tajikistan Togo United Republic of Tanzania (the) Uzbekistan Viet Nam Zambia Zimbabwe
Non Gavi countries with formal commitment to introduce in 2017
Cabo Verde, Egypt, Turkmenistan
Since January 2013, the following countries have introduced IPV: Kazakhstan, Peru & Singapore (July 2013); Micronesia (August 2013); Libya (April 2014); Albania & Panama (May 2014); Nepal & Tunisia (September 2014); Philippines (October 2014); China (December 2014); Comoros, Senegal & Serbia (January 2015); Colombia & Nigeria (February 2015); Bangladesh & Maldives (March 2015); DR Congo, DPR Korea & The Gambia (April 2015); Madagascar (May 2015); Cote d'Ivoire, Grenada, Kiribati, Morocco, St Vincent and the Grenadines & Sudan (June 2015); Bhutan, Cameroon, Niger, Pakistan, Philippines & Sri Lanka (July 2015); Benin, Chad, Papua New Guinea, The Former Yug. Rep. of Macedonia (August 2015); Afghanistan, CAR, Dominica, Guyana, Iran, Jamaica, Seychelles & Solomon Islands (September 2015); Bahamas, Lao People's Dem Rep, Nauru, Samoa (October 2015); Antigua and Barbuda, Botswana, Burundi, Cook Islands, Guinea, India, Mauritania, Mauritius, Mozambique, Namibia, Nicaragua, St Lucia, Suriname, Tuvalu, Vanuatu & Yemen (November 2015); Algeria, Belize, Cambodia, Dominical Rep, Ecuador, Ethiopia, Fiji, Gabon, Georgia, Honduras, Kenya, Myanmar, Paraguay, St Kitts & Nevis, S. Sudan, Thailand, Tonga & Trinidad & Tobago (December 2015); Cuba, El Salvador, Guatemala, Haiti, Iraq & Venezuela (Bolivian Rep of) (January 2016); Azerbaijan, Bolivia & Timor-Leste (February 2016); Chile & Mali (March 2016); Argentina, Congo, Djibouti, Lesotho, Sao Tome & P., Uganda (April 2016); Armenia, Guinea-Bissau, Indonesia & Swaziland (July 2016); Eq. Guinea (August 2016)
Introduced to date* (173 countries or 89%)
Gavi countries with formal commitment to introduce in (18 countries or 9%)
Non Gavi countries with formal commitment to introduce in (3 countries or 2%)
Not available
Not applicable
Data source: WHO/IVB Database, as of 07 November 2016
Map production Immunization Vaccines and Biologicals (IVB),
World Health Organization
* Including partial introduction in India
The boundaries and names shown and the designations used on this map do not imply the expression of any opinion whatsoever on the part of the World Health Organization concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries. Dotted lines on maps represent approximate border lines for which there may not yet be full agreement. ©WHO All rights reserved.
Date of slide: 7 November 2016

5. 21 countries introducing IPV between 7 November 2016 and December 2017
World Health Organization
21 countries introducing IPV between 7 November 2016 and December 2017
20 July, 2018
Oct-17
Dec-17
Cabo Verde
Angola
Burkina Faso
Egypt
Eritrea
Ghana
Kyrgyzstan
Liberia
Malawi
Mongolia
Rep. of Moldova
Rwanda
Sierra Leone
Tajikistan
Togo
Turkmenistan
United Rep. of Tanzania
Uzbekistan
Viet Nam
Zambia
Zimbabwe 1 20
Data source: WHO/IVB Database, as of 07 November 2016
Map production Immunization Vaccines and Biologicals (IVB),
World Health Organization
Date of slide: 7 November 2016

6. World Health Organization
Tier 1 and 2 Countries using IPV vaccine to date and formal decision to introduce
World Health Organization
20 July, 2018
Introduction to date
Afghanistan, Azerbaijan, Benin, Cambodia, Cameroon, Central African Republic (the), Chad, China, Congo (the), Dominican Republic (the), DR Congo, Equatorial Guinea, Ethiopia, Gabon, Guinea, Haiti, India, Indonesia, Iraq, Kenya, Lao People's Democratic Republic (the), Madagascar, Mali, Mauritania, Mozambique, Myanmar, Niger (the), Nigeria, Pakistan, Papua New Guinea, Philippines (the), Somalia, South Sudan, Timor-Leste, Uganda, Yemen
Not Applicable or not Tier 1 or 2 countries
Angola, Albania, Andorra, United Arab Emirates (the), Argentina, Armenia, Antigua and Barbuda, Australia, Austria, Burundi, Belgium, Burkina Faso, Bangladesh, Bulgaria, Bahrain, Bahamas (the), Bosnia and Herzegovina, Belarus, Belize, Bolivia (Plurinational State of), Brazil, Barbados, Brunei Darussalam, Bhutan, Botswana, Canada, Switzerland, Chile, Cote d'Ivoire, Cook Islands, Colombia, Comoros (the), Cabo Verde, Costa Rica, Cuba, Cyprus, Czech Republic (the), Germany, Djibouti, Dominica, Denmark, Algeria, Ecuador, Egypt, Eritrea, Spain, Estonia, Finland, Fiji, France, Micronesia (Federated States of), United Kingdom of Great Britain and Northern Ireland (the), Georgia, Ghana, Gambia (the), Guinea-Bissau, Greece, Grenada, Guatemala, Guyana, Honduras, Croatia, Hungary, Ireland, Iran (Islamic Republic of), Iceland, Israel, Italy, Jamaica, Jordan, Japan, Kazakhstan, Kyrgyzstan, Kiribati, Saint Kitts and Nevis, Rep of Korea, Kuwait, Lebanon, Liberia, Libya, Saint Lucia, Sri Lanka, Lesotho, Lithuania, Luxembourg, Latvia, Morocco, Monaco, Republic of Moldova (the), Maldives, Mexico, Marshall Islands (the), The former Yugoslav Republic of Macedonia, Malta, Montenegro, Mongolia, Mauritius, Malawi, Malaysia, Namibia, Nicaragua, Niue, Netherlands (the), Norway, Nepal, Nauru, New Zealand, Oman, Panama, Peru, Palau, Poland, DPR Korea, Portugal, Paraguay, Qatar, Romania, Russian Federation (the), Rwanda, Saudi Arabia, Sudan (the), Senegal, Singapore, Solomon Islands, Sierra Leone, El Salvador, San Marino, Serbia, Sao Tome and Principe, Suriname, Slovakia, Slovenia, Sweden, Swaziland, Seychelles, Syrian Arab Republic (the), Togo, Thailand, Tajikistan, Turkmenistan, Tonga, Trinidad and Tobago, Tunisia, Turkey, Tuvalu, United Republic of Tanzania (the), Ukraine, Uruguay, United States of America (the), Uzbekistan, Saint Vincent and the Grenadines, Venezuela (Bolivarian Republic of), Viet Nam, Vanuatu, Samoa, South Africa, Zambia, Zimbabwe
Since January 2013, the following Tier 1 and 2 countries have introduced IPV:
The Philippines (October 2014), China (December 2014), Nigeria (February 2015), DR Congo (April 2015), Madagascar (May 2015), Cameroon, Niger and Pakistan (July 2015); Benin, Chad and Papua New Guinea (August 2015); Afghanistan and CAR (September 2015); Lao People's Democratic Republic (October 2015); Guinea, India, Mauritania, Mozambique, Somalia & Yemen (November 2015); Cambodia, Dominican Rep., Ethiopia, Gabon, Kenya, Myanmar & S. Sudan (December 2015); Haiti & Iraq (January 2016); Azerbaijan, Bolivia & Timor-Leste (February 2016); Mali (March 2016); Congo & Uganda (April 2016); Indonesia (July 2016); Eq. Guinea (August 2016)
Introduced to date* (36 countries or 100%)
Not Applicable / not available / Tier 1 or 2 countries
Tier 1 countries are countries with cVDPV2 transmission or cVDPV2 reported since 2000 & WPV endemic countries
Tier 2 countries are countries with cVDPV 1/3 since 2000 or large /Medium size countries
with DTP3 coverage <80% in the past 3 years as per WUENIC
Data source: WHO/IVB Database, as of 07 November 2016,
based on 36 tier 1 & 2 countries
Map production Immunization Vaccines and Biologicals (IVB),
World Health Organization
The boundaries and names shown and the designations used on this map do not imply the expression of any opinion whatsoever on the part of the World Health Organization concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries. Dotted lines on maps represent approximate border lines for which there may not yet be full agreement. ©WHO All rights reserved.
Date of slide: 7 November 2016

7. World Health Organization
Middle Income Countries using IPV vaccine to date and formal decision to introduce
World Health Organization
20 July, 2018
Introduced to date
Albania Algeria Armenia Azerbaijan Bangladesh Belarus Belize Bhutan Bolivia (Plurinational State of) Bosnia and Herzegovina Botswana Brazil Bulgaria Cambodia Cameroon China Colombia Congo (the) Costa Rica Cote d'Ivoire Cuba Djibouti Dominica Dominican Republic (the) Ecuador El Salvador Equatorial Guinea Fiji Gabon Georgia Grenada Guatemala Guyana Honduras India Indonesia Iran (Islamic Republic of) Iraq Jamaica Jordan Kazakhstan Kenya Kiribati Lao People's Democratic Republic (the) Lebanon Lesotho Libya Malaysia Maldives Marshall Islands (the) Mauritania Mauritius Mexico Micronesia (Federated States of) Montenegro Morocco Myanmar Namibia Nicaragua Nigeria Pakistan Palau Panama Papua New Guinea Paraguay Peru Philippines (the) Romania Russian Federation (the) Saint Lucia Saint Vincent and the Grenadines Samoa Sao Tome and Principe Serbia Solomon Islands South Africa Sri Lanka Sudan (the) Suriname Swaziland Syrian Arab Republic (the) Thailand The former Yugoslav Republic of Macedonia Timor-Leste Tonga Tunisia Turkey Tuvalu Ukraine Vanuatu Venezuela (Bolivarian Republic of) Yemen
Formal commitment to introduce in 2017
Angola Cabo Verde Egypt Ghana Kyrgyzstan Mongolia Republic of Moldova (the) Tajikistan Turkmenistan Uzbekistan Viet Nam Zambia
Not Available / Not introduced / No Plans
Afghanistan Andorra Antigua and Barbuda Argentina Australia Austria Bahamas (the) Bahrain Barbados Belgium Benin Brunei Darussalam Burkina Faso Burundi Canada Central African Republic (the) Chad Chile Comoros (the) Cook Islands Croatia Cyprus Czech Republic (the) Denmark DPR Korea DR Congo Eritrea Estonia Ethiopia Finland France Gambia (the) Germany Greece Guinea Guinea-Bissau Haiti Hungary Iceland Ireland Israel Italy Japan Kuwait Latvia Liberia Lithuania Luxembourg Madagascar Malawi Mali Malta Monaco Mozambique Nauru Nepal Netherlands (the) New Zealand Niger (the) Niue Norway Oman Poland Portugal Qatar Rep of Korea Rwanda Saint Kitts and Nevis San Marino Saudi Arabia Senegal Seychelles Sierra Leone Singapore Slovakia Slovenia Somalia South Sudan Spain Sweden Switzerland Togo Trinidad and Tobago Uganda United Arab Emirates (the) United Kingdom of Great Britain and Northern Ireland (the) United Republic of Tanzania (the) United States of America (the) Uruguay Zimbabwe
Since January 2013, the following MIC have introduced IPV: Kazakhstan (July 2013); Peru (July 2013); Libya (March 2014); Albania (May ); Panama (July 2014); Tunisia (September 2014); Philippines (October 2014); China (December 2014); Senegal (January 2015); Serbia (January 2015); Colombia (February 2015); Maldives (March 2015) and Cote d'Ivoire, Kiribati, Morocco, St Vincent and the Grenadines & Sudan (June 2015); Bhutan, Cameroon, Pakistan & Sri Lanka (July 2015); Papua New Guinea & the former Yugoslav Rep. of Macedonia (August 2015); Dominica, Guyana, Iran, Jamaica & Solomon Islands (September 2015); Lao People's Democratic Rep & Samoa (October 2015); Botswana, India, Mauritania, Mauritius, Namibia, Nicaragua, St Lucia, Tuvalu , Vanuatu & Yemen (November 2015); Algeria, Belize, Dominican Rep, Ecuador, Fiji, Gabon, Georgia, Honduras, Kenya, Myanmar, Paraguay, Thailand & Tonga (December 2015); Cuba, El Salvador, Iraq & Guatemala (January 2016); Azerbaijan, Bolivia & Timor-Leste (February 2016); Congo, Djibouti, Lesotho & Sao Tome & P. (April 2016); Armenia, Indonesia & Swaziland (July 2016); Eq. Guinea (August 2016)
Introduced to date (92 countries or 88%)
Not applicable / Not available / Not introduced / Non MIC
Formal commitment to introduce in (12 countries or 12%)
Data source: WHO/IVB Database, as of 07 November 2016 based on 104
middle income countries (MIC) as per last World Bank classification
Map production Immunization Vaccines and Biologicals (IVB),
World Health Organization
The boundaries and names shown and the designations used on this map do not imply the expression of any opinion whatsoever on the part of the World Health Organization concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries. Dotted lines on maps represent approximate border lines for which there may not yet be full agreement. ©WHO All rights reserved.
Date of slide: 7 November 2016

8. World Health Organization
20 July, 2018
Overview of Global birth cohort by IPV status/tier (100% = million births in 2016)
* Partial Introduction
Data source: WHO/IVB Database, as of 07 November 2016 and United Nations, Department of Economic and Social Affairs, Population Division (2015). World Population Prospects: The 2015 Revision

9. bOPV registration status for routine immunization
World Health Organization
20 July, 2018
Approval for use
Afghanistan, Albania, Algeria, Angola, Antigua and Barbuda, Argentina, Armenia, Azerbaijan, Bahamas (the), Bahrain, Bangladesh, Barbados, Belize, Benin, Bhutan, Bolivia (Plurinational State of), Bosnia and Herzegovina, Botswana, Brazil, Burkina Faso, Burundi, Cabo Verde, Cambodia, Cameroon, Central African Republic (the), Chile, China, Colombia, Comoros (the), Congo (the), Cook Islands, Cote d'Ivoire, Djibouti, Dominica, Dominican Republic (the), DPR Korea, DR Congo, Ecuador, Egypt, El Salvador, Equatorial Guinea, Fiji, Gabon, Gambia (the), Georgia, Ghana, Grenada, Guatemala, Guinea, Guinea-Bissau, Guyana, Haiti, Honduras, India, Indonesia, Iran (Islamic Republic of), Iraq, Israel, Jamaica, Jordan, Kazakhstan, Kenya, Kiribati, Kuwait, Kyrgyzstan, Lao People's Democratic Republic (the), Lebanon, Lesotho, Liberia, Libya, Madagascar, Malawi, Maldives, Mali, Mauritius, Mexico, Mongolia, Myanmar, Nauru, Nepal, Nicaragua, Niger (the), Nigeria, Oman, Pakistan, Panama, Papua New Guinea, Paraguay, Peru, Philippines (the), Republic of Moldova (the), Russian Federation (the), Rwanda, Saint Kitts and Nevis, Saint Lucia, Saint Vincent and the Grenadines, Samoa, Sao Tome and Principe, Saudi Arabia, Serbia, Seychelles, Sierra Leone, Singapore, Solomon Islands, Somalia, South Africa, South Sudan, Sri Lanka, Sudan (the), Suriname, Swaziland, Syrian Arab Republic (the), Tajikistan, Thailand, The former Yugoslav Republic of Macedonia, Timor-Leste, Tonga, Trinidad and Tobago, Turkmenistan, Ukraine, United Arab Emirates (the), Uzbekistan, Vanuatu, Venezuela (Bolivarian Republic of), Viet Nam, Yemen
Approval for use (144 countries)
Data source: WHO/IVB Database, as of 7 November 2016
based on 148 OPV user countries and 7 Territories
Map production Immunization Vaccines and Biologicals (IVB),
World Health Organization
Not available/ non switch countries
(46 countries) + 4 countries switching from tOPV to IPV
Not applicable (switch area territories)
The boundaries and names shown and the designations used on this map do not imply the expression of any opinion whatsoever on the part of the World Health Organization concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries. Dotted lines on maps represent approximate border lines for which there may not yet be full agreement. ©WHO All rights reserved.
Date of slide: 7 November 2016